The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase Ib study testing neoadjuvant transforming growth factor (TGF)-β antibody, NIS793, plus 5-fluorouracil, irinotecan, and oxaliplatin chemotherapy (FOLFIRINOX) in patients (pts) with borderline resectable (BR)/locally advanced (LA) pancreatic ductal adenocarcinoma (PDAC).
 
Colin D. Weekes
Honoraria - Bayer; Celgene; Lilly
Consulting or Advisory Role - Celgene; Ipsen; Merrimack
Research Funding - Actuate Therapeutics; AstraZeneca; Celgene; Dicephera Pharmaceuticals, Inc.; Genentech/Roche; Novartis
 
David Tsai Ting
Leadership - PanTher Therapeutics
Stock and Other Ownership Interests - PanTher Therapeutics; ROME Therapeutics; TellBio
Consulting or Advisory Role - Ikena Oncology; NanoString Technologies; Pfizer; ROME Therapeutics; Tekla Capital Management
Research Funding - ACD Biotechne (Inst); PureTech (Inst); Ribon Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Patent License to PanTher Therapeutics (Inst); Patent License to TellBio Inc. (Inst); Patent licensed to Rome Therapeutics by my Institution. (Inst)
 
Aparna Raj Parikh
Consulting or Advisory Role - Abbvie; Bayer; Biofidelity; Checkmate Pharmaceuticals; CVS; Delcath Systems; Delcath Systems; Foundation Medicine; Genconn Biotech; Genconn Biotech; Guardant Health; Illumina; Inivata; Lilly; Natera; Pfizer; Roche/Genentech; SAGA Diagnostics; Scarce; Seagen; Taiho Oncology; UpToDate; Value Analytics Labs; xCures; xCures
Research Funding - Array BioPharma (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Erasca, Inc; Genentech (Inst); Guardant Health (Inst); Lilly (Inst); Mirati Therapeutics (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Plexxikon (Inst); PMV Pharma; PureTech (Inst)
Other Relationship - C2i genomics; Parithera; Xact Robotics
 
Stacie Ittershagen
Employment - Novartis
Stock and Other Ownership Interests - Novartis
Patents, Royalties, Other Intellectual Property - Oregon Health & Science University: Cell Free Screening Assay and Methods of Use, U.S. Patent awarded 10/4/2011 #8,030,004; Oregon Health & Science University: Commercial technology transfer of four antibodies to Novus Biologicals
Travel, Accommodations, Expenses - Novartis
 
Claire Fabre
Employment - Novartis
Stock and Other Ownership Interests - Novartis
 
Viviana Cremasco
Employment - Novartis Institutes for BioMedical Research
Stock and Other Ownership Interests - Novartis Institutes for BioMedical Research
Research Funding - Novartis Institutes for BioMedical Research
Patents, Royalties, Other Intellectual Property - Novartis Institutes for BioMedical Research
 
David Ruddy
Employment - Novartis Institutes for BioMedical Research
Stock and Other Ownership Interests - Exelixis; Novartis Institutes for BioMedical Research
Research Funding - Novartis Institutes for BioMedical Research
Patents, Royalties, Other Intellectual Property - Novartis Institutes for BioMedical Research
Travel, Accommodations, Expenses - Novartis Institutes for BioMedical Research
 
Andrew Liss
Employment - Constellation Pharmaceuticals; Flare Therapeutics
Stock and Other Ownership Interests - Constellation Pharmaceuticals; Flare Therapeutics
Research Funding - Novartis Pharmaceuticals UK Ltd.
 
Aileen O'Shea
No Relationships to Disclose
 
Mukesh Harisinghani
No Relationships to Disclose
 
Michelle Piquet
Employment - Novartis Institutes for BioMedical Research
 
Jonathan Chang
Employment - Novartis Institutes for BioMedical Research
 
Eunice Lee Kwak
Employment - Novartis Institutes for BioMedical Research
Stock and Other Ownership Interests - Novartis Institutes for BioMedical Research
Patents, Royalties, Other Intellectual Property - Novartis Institutes for BioMedical Research
 
David P. Ryan
Stock and Other Ownership Interests - Acworth Pharmaceuticals; Bioimpact Capital; Cullinan Oncology; Exact Sciences; MPM Capital; Thrive Earlier Detection Corp
Honoraria - Research to Practice; UpToDate
Consulting or Advisory Role - Gritstone Bio; Innocrin Pharma; Maverick Therapeutics; MPM Capital; Oncorus; TCR2 Therapeutics; Twentyeight-Seven Therapeutics
Research Funding - Stand up to Cancer (Inst)
Patents, Royalties, Other Intellectual Property - Johns Hopkins University Press; McGraw Hill Chapter Royalties
Expert Testimony - Boehringer Ingelheim
Other Relationship - TCR2 Therapeutics